SEP 11, 2018 10:43 PM PDT

Stimuli-Responsive Nanoparticles as a Drug Delivery Method

WRITTEN BY: Nouran Amin

Image Credit: Phys.Org

Researchers at Washington State University (WSU), who were finding a way to fight an inflammatory response that causes organ failure better known as sepsis, show that stimuli-responsive nanoparticles can target infections to simultaneously inhibit the spread of bacteria and decrease inflammation. Such microscopic particles include abundant antibiotic and anti-inflammatory agents that are released when the particles encounter an infection in the body.

"This study not only proves a new drug delivery system but also may shift the current landscape in nanomedicine to a biology-driven design of nanotherapeutics. This has the potential to improve the therapies of many more infectious diseases," explains Zhenjia Wang, a pharmaceutical sciences professor.

The research study, published in the journal Advanced Materials, shows how WSU scientists developed a new nanoparticle that is coated with compounds that are commonly secreted by blood vessels in response to an infection. The nanoparticle is sensitive to infections sites allowing the bacterial enzymes to be triggered for the release of drugs.

Image Credit: Structure of a nanoparticle via Kaust.edu

Although with antibiotics and anti-inflammatories are used to mitigate the onset of sepsis, there remain issues with “old school use of these therapies”. "This study will allow chemists and materials engineers to design new drug formulations to treat many bacterial infections, such as TB infection," explains Can Yang Zhang, who is the leading author on the paper and a postdoctoral research associate in the Wang lab.

In medicine, nanoparticle technology is growing, however, it is a first time that a nanocarrier has been developed to deliver not one, but two drugs. Furthermore, nanocarrier specifically targets infection sites, so less medicine may be a needed to fix collateral damage to otherwise healthy tissues.

Source: Washington State University, Advanced Materials

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 17, 2018
Videos
JUL 17, 2018
Novartis Ends Antibiotic Research
The United Nations has warned that by 2050, antibiotic-resistant microbes might kill ten million people every year....
AUG 08, 2018
Videos
AUG 08, 2018
A Harbinger of Hope for Alzheimer's Patients?
The search for effective treatments for Alzheimer’s disease is ongoing, but overall, hasn’t been productive. Many companies, like pharmaceutica...
AUG 27, 2018
Cardiology
AUG 27, 2018
Drug Reduces Deaths and Hospitalization from Heart Failure
New drug reduces deaths and hospitalization rates, while also improving quality of life, for patients with rare type of cardiomyopathy....
SEP 04, 2018
Drug Discovery
SEP 04, 2018
Dopamine Provided Targeted Therapy for Neuropsychiatric Disorders
According to a study published in Molecular Psychiatry, research scientists at Columbia University Vagelos College of Physicians and Surgeons have brought ...
OCT 01, 2018
Cell & Molecular Biology
OCT 01, 2018
Revealing How Antibiotics Work Against Bacteria
In a first, researchers have directly observed an antibiotic in action as it disrupted the membrane of a bacterial cell....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
Loading Comments...